ArticleMedicine2026
Gender and racial differences in the relationship between mean arterial pressure, pulse pressure, and cognitive function in older adults: NHANES 2011 to 2014.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impacts of mean arterial pressure (MAP) and pulse pressure (PP) on cognitive decline have not been fully characterized, and little is known about the gender and racial differences in this relationship. This study aimed to look into the above-mentioned relationship. Information was obtained from the National Health and Nutrition Examination Survey 2011 to 2014. The Consortium to Establish a Registry for Alzheimer's Disease Word Learning Test (CERAD W-L), the Animal Fluency Test, and the Digit Symbol Substitution Test (DSST) were used to assess cognitive functioning in participants aged 60 years and older. Weighted linear regression analyses were employed to detect the relationship between MAP, PP (continuous or quartiles), and 3 cognitive test scores. Additionally, forest maps and smooth curve fitting were utilized to demonstrate subgroup analyses stratified by gender and race. There were 2612 participants in this study. After fully adjusting for covariates, MAP was negatively correlated with cognitive functioning estimated by CERAD W-L (β: -0.026, 95% confidence interval [CI]: -0.045 to -0.008), and PP was negatively associated with cognitive test scores through DSST (β: -0.039, 95% CI: -0.065 to -0.013). This tendency remained statistically significant across different MAP quartile groups and PP quartile groups (P for trend < .01). In the CERAD W-L test, subgroup analyses stratified by race as well as sex revealed that the negative relationship between MAP, PP, and cognitive scores remained significant in females (MAP: β: -0.042, 95% CI: -0.066 to -0.017; PP: β: -0.018, 95% CI: -0.033 to -0.002) and non-Hispanic White (NHW; MAP: β: -0.031, 95% CI: -0.052 to -0.010; PP: β: -0.016, 95% CI: -0.029 to -0.002). Additionally, a negative relationship between PP and cognitive scores was also found in DSST in females (β: -0.044, 95% CI: -0.077 to -0.011) and NHW (β: -0.041, 95% CI: -0.070 to -0.012). Our study suggested that elevated levels of MAP and PP were negatively correlated with cognitive functioning, particularly in females and NHWs. Therefore, the management of MAP and PP might be helpful for the prevention of poor cognitive performance in the elders. However, the cross-sectional nature of this study limits causal inference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.